] As of Mar. 20 09:10 A.M., Kwangdong Pharmaceutical declined 1.02%, compared with yesterday, to 8,720 won (US$7.72). It had declined 2.57% through the past month. Standard deviation, which indicates risk, records 1.3% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, Kwangdong Pharmaceutical was not only the most satisfactory in investment return among its peer group, but its volatility was also the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.9%. Compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.8, and thus the industrial comparison performance was not so good.
By HeRo (firstname.lastname@example.org
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.